1-6 of 6
Susan Robson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A with FVIII Inhibitors: Final Analysis

Giancarlo Castaman, Jerzy Windyga, Hazza Alzahrani, Susan Robson, Fabian Sanabria, Monet Howard, Víctor Jiménez-Yuste
Journal: Blood
Blood (2021) 138 (Supplement 1): 344.
https://doi.org/10.1182/blood-2021-145890
Published: 2021
Journal Articles

Safety of Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Results from the Primary Analysis of the Phase 3b GREEN Study

Stephan Stilgenbauer, MD PhD, Melih Aktan, Christelle M Ferra Coll, Caroline Dartigeas, Jens Kisro, Marco Montillo, MD, João Raposo, Jean-Louis Merot, Susan Robson, Ekaterina Gresko, Francesc Bosch, Robin Foà, MD, Véronique Leblond
Journal: Blood
Blood (2017) 130 (Supplement 1): 4309.
https://doi.org/10.1182/blood.V130.Suppl_1.4309.4309
Published: 2017
Journal Articles

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Magdalena Klanova, MD, Mikkel Z. Oestergaard, Marek Trněný, MD PhD, Wolfgang Hiddemann, MD PhD, Robert Marcus, Laurie H. Sehn, MDMPH, Umberto Vitolo, MD, Alexandra Bazeos, Valentin Goede, MD, Harald Zeuner, Andrea Knapp, Denis Sahin, Nathalie Danesi, Christopher Bolen, Susan Robson, Jeffrey M. Venstrom, Tina Nielsen, Günter Fingerle-Rowson
Journal: Blood
Blood (2017) 130 (Supplement 1): 727.
https://doi.org/10.1182/blood.V130.Suppl_1.727.727
Published: 2017
Journal Articles

Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study

Veronique Leblond, Guy Cantin, MD, Agostino Cortelezzi, Prof, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, MD, Andrey Zaritskey, Jean-Louis Merot, Kerstin Trunzer, Susan Robson, Ekaterina Gresko, Stephan Stilgenbauer, MD PhD, Robin Foà, Francesc Bosch
Journal: Blood
Blood (2017) 130 (Supplement 1): 3015.
https://doi.org/10.1182/blood.V130.Suppl_1.3015.3015
Published: 2017
Journal Articles

Assessment of Measures to Reduce Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab in the GREEN Study

Francesc Bosch, Robin Foà, Agostino Cortelezzi, MD, Jens Kisro, Veronique Leblond, Gayane Tumyan, Ekaterina Gresko, Susan Robson, Stephan Stilgenbauer
Journal: Blood
Blood (2016) 128 (22): 5589.
https://doi.org/10.1182/blood.V128.22.5589.5589
Published: 2016
Journal Articles

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-Basket Study

Eli L. Diamond, Vivek Subbiah, Craig Lockhart, Jean-Yves Blay, Jason E. Faris, Igor Puzanov, Ian Chau, Noopur S. Raje, Jürgen S. Wolf, Joe Erinjeri, Jean Torrisi, Gary Ulaner, Mario Lacouture, Susan Robson, Martina Makrutzki, Elena Elez, Josep Tabernero, Omar Abdel-Wahab, MD, Jose Baselga, David M. Hyman
Journal: Blood
Blood (2016) 128 (22): 480.
https://doi.org/10.1182/blood.V128.22.480.480
Published: 2016